Skip to main content

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioSolutions was attributable to sustained growth in sales to agriculture. In BioMaterials, higher sales prices were more than offset by lower sales volume. Fine chemical intermediates delivered a strong result. Net currency effects were positive across all areas. Profit before tax was NOK 247 million (NOK 326 million)....

Continue reading

Coop Pank unaudited financial results for Q3 2025

By the end of the Q3 2025, Coop Pank had 222,000 customers, increased by 4,000 customers in the quarter (+2%) and by 20,000 in the year (+10%). The bank had 105,400 active customers, increased by 1,800 (+2%) in the quarter and by 10,000 (+10%) in the year. In Q3 2025, volume of deposits in Coop Pank increased by 105 million euros (+6%), reaching total of 1.91 billion euros. Deposits from private customers increased by 9 million euros: demand deposits remained at the same level compared to the previous quarter and term deposits increased by 9 million euros. Deposits from domestic business customers increased by 24 million euros: demand deposits increased by 44 million euro and term deposits decreased by 20 million euros. Deposits from international deposit platform increased by 71 million euros and other financing increased by 40 million...

Continue reading

Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance

Year-to-date total sales growth of 12.1% at CER1, or 9.6% as reported, driven by all three therapeutic areas and including strong performance from Iqirvo®, Bylvay® and Somatuline® Further upgrade of full-year 2025 financial guidance based on slower than anticipated erosion of Somatuline® and accelerated sales growth of the rest of the portfolio: total sales growth of around 10.0%2 at CER (prior guidance greater than 7.0%); core operating margin of around 35.0% of total sales (prior guidance greater than 32.0%) Announcement today of the proposed acquisition of ImCheck Therapeutics bringing a first-in-class Phase II asset, expanding pipeline in oncologyPARIS, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third...

Continue reading

Teck Reports Unaudited Third Quarter Results for 2025

Merger of equals to create new global critical minerals champion and unlock substantial value VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (Teck) today announced its unaudited third quarter results for 2025. “The merger of equals between Teck and Anglo American announced this quarter is a unique opportunity to create a global leader in critical minerals and a top five copper producer,” said Jonathan Price, President and CEO. “The combination will unlock significant value for shareholders through integration of Quebrada Blanca and Collahuasi and meaningful corporate synergies, offering a compelling high-quality, copper-focused investment opportunity. In addition, we completed a Comprehensive Operational Review to ensure our business plans...

Continue reading

Heineken Holding N.V. reports on 2025 third quarter trading

Amsterdam, 22 October 2025 – Heineken Holding N.V. (HEIO; HKHHY) announces Staying the course while navigating a challenging quarterKey Quarterly HighlightsRevenue €8,712 million for the quarter, €25,636 million year to dateNet revenue (beia) organically down 0.3% for the quarter, up 1.3% year to dateBeer volume organically down 4.3% for the quarter, down 2.3% year to datePremium beer volume organically down 2.2% for the quarter, up 0.4% year to dateHeineken® volume down 0.6% for the quarter, up 2.7% year to date2025 organic operating profit (beia) growth anticipated to be towards the lower end of the 4% to 8% guidanceHeineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company.Enquiries...

Continue reading

GCC Reports Third Quarter 2025 Results

CHIHUAHUA, Mexico, Oct. 21, 2025 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading supplier and producer of cement, aggregates, and concrete in the United States and Mexico, announced today its results for the third quarter of 2025. Q3 2025 HIGHLIGHTSConsolidated net sales increased 10.1% year-on-year to US$438.5 million U.S. sales grew 14% as concrete and cement volumes increased 52.7% and 6.4%, respectively U.S. concrete prices increased 11% EBITDA decreased 2.9% to US$157.4 million, with a 35.9% EBITDA margin Cash and equivalents totaled US$853.7 million Net leverage (net debt/EBITDA) ratio totaled -0.55x as of September 2025 Earnings per share decreased 6.1% year-on-year, to US$0.3076 Free cash flow totaled US$132.4 million with an 84.1% free cash flow conversion rate GCC repurchased shares in the net amount of...

Continue reading

Happy City Holdings Limited Announces Financial Results for the First Half of Fiscal Year 2025

HONG KONG, Oct. 21, 2025 (GLOBE NEWSWIRE) — Happy City Holdings Limited (Nasdaq: HCHL) (the “Company”), an established all-you-can-eat hotpot restaurant operator in Hong Kong , today announced its unaudited financial results for the six months ended February 28, 2025 (the “First Half of Fiscal Year 2025”).Financial Highlights for the First Half of Fiscal Year 2025         For the six months ended   Variance  February 28,2025   February 29,2024   Amount   Percentage  US$   US$   US$   %  (Unaudited)   (Unaudited)        Revenue $ 4,160,099     $ 3,437,904     $ 722,195     21.0 %Cost of revenue   (3,113,028 )     (3,043,454 )     (69,574 )   2.3 %Gross profit   1,047,071       394,450       652,621     165.5 %Total operating expenses   (638,812 )     (558,345 )     (80,467 )   14.4 %Income (loss)...

Continue reading

National Bank Holdings Corporation Announces Third Quarter 2025 Financial Results

DENVER, Oct. 21, 2025 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (the “Company” or “NBHC”) reported:    For the quarter(1)   For the nine months ended(1)   2025 Adjusted(2)    3Q25   2Q25   3Q24   3Q25   3Q24   QTD   YTDNet income ($000’s)   $ 35,285     $ 34,022     $ 33,105     $ 93,538     $ 90,631     $ 36,621     $ 94,874  Earnings per share – diluted   $ 0.92     $ 0.88     $ 0.86     $ 2.43     $ 2.36     $ 0.96     $ 2.47  Return on average assets     1.43 %     1.38 %     1.32 %     1.27 %     1.22 %     1.48 %     1.29 %Return on average tangible assets(2)     1.54 %     1.49 %     1.43 %     1.38 %     1.33 %     1.60 %     1.40 %Return on average equity     10.25 %     10.15 %     10.33 %     9.30 %     9.70 %     10.64 %     9.43 %Return on average tangible common...

Continue reading

LifeVantage to Announce First Quarter Fiscal Year 2026 Results on November 4, 2025

SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2025, after the stock market closes on Tuesday, November 4, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, November 18, 2025, by dialing (844) 512-2921 from the U.S. and entering confirmation...

Continue reading

Orrstown Financial Services, Inc. Reports Third Quarter 2025 Results

Net income of $21.9 million, or $1.13 per diluted share, for the three months ended September 30, 2025 compared to net income of $19.4 million, or $1.01 per diluted share, for the three months ended June 30, 2025; excluding the impact of $1.0 million in merger-related expenses, net of taxes, net income and diluted earnings per share for the second quarter of 2025 were $20.2 million(1) and $1.04(1), respectively; Return on average assets was 1.60% and return on average equity was 15.72% for the three months ended September 30, 2025, compared to 1.45% and 14.56% for the return on average assets and return on average equity, respectively, for the three months ended June 30, 2025; Excluding the impact of the merger-related expenses referenced above, net of taxes, adjusted return on average assets and adjusted return on average equity were...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.